TMO NYSE Week ended 24 Jul 2026

Weekly Investor Report

Thermo Fisher Scientific Inc · Healthcare · Diagnostics & Research

Open interactive chart View report data Download investor PDF
Latest close 568.3 USD
6.7% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 10.9% above the Trend Line and sits at 64.2% of its 52-week range. The latest completed week returned 6.7%, after a 10.8% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is expensive relative to peers. Options positioning is bullish with 36/100 conviction, while the latest news-sentiment score is 54/100. Near-term considerations: earnings are due in 84d.

Setup score 57 out of 100
Latest Close 568.3 USD 24 Jul 2026
1W Return 6.7% latest completed week
4W Return 10.8% short-term follow-through
12W Return 21.2% quarterly tape
Trend Breadth 40.4% 21 of 52 weeks active
Volume Ratio 1.4x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
  • Latest weekly return ranks in the strongest part of its sector group.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 6.7% Latest completed week; four-week move 10.8%. Indicator stack 22/89 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 36/100 conviction; expected move 3.4%. News sentiment 54/100 39 relevant articles in the latest sentiment read. Event risk 84d Next report is scheduled for 21 Oct 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 10.9% above the Trend Line and sits at 64.2% of its 52-week range. The latest completed week returned 6.7%, after a 10.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2212-week average 0.07

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.22Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 10.8% over four weeks, 21.2% over 12 weeks, and 19.2% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W6.7%
4W10.8%
12W21.2%
26W-9.0%
52W19.2%
Active trend streak0 weeks
Active weeks in one year21
Trend breadth40.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.90Latest activity-pressure read.
Pressure change288.5%Four-week change in activity pressure.
Leadership1.00Latest relative-leadership reading.
RS change113.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 97% Model confidence 97%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength25/100Blend of value, momentum, and quality. Underlying universe rank 76; rank 1 is best.
Value9/100Relative valuation strength. Underlying universe rank 92; rank 1 is best.
Quality69/100Profitability and accounting quality. Underlying universe rank 32; rank 1 is best.
Momentum67/100Medium-term price momentum. Underlying universe rank 34; rank 1 is best.
Growth20/100Revenue and earnings growth. Underlying universe rank 81; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework33/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
30.3x
Price divided by trailing earnings.
Price / sales
4.6x
Market value relative to trailing revenue.
EV / EBITDA
22.8x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
4.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
40.4%
Gross profit retained from each unit of revenue.
Operating margin
18.6%
Operating profit retained from revenue.
Free-cash-flow margin
23.1%
Free cash flow generated from revenue.
Return on invested capital
8.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
7.2%
Latest one-year revenue growth.
EPS growth
6.0%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
19.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.3%
Cash dividends relative to market value.
Buyback yield
1.4%
Net share repurchases relative to market value.
Shareholder yield
1.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

TMO shows bullish options pressure with a 36/100 conviction score, put-call volume ratio of 0.53, expected move of 3.4%, and Sharemaestro trend signal inactive.

Conviction36/100
Expected move3.4%
Put/call volume0.53
Pressure33
Speculation41
Volatility43
Trend agreement35
Open options detail
Insider activity18 / 2

18 acquisitions and 2 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment54/100

Weighted news tone is neutral across 39 relevant articles.

13 positive · 24 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings84dNext report is scheduled for 21 Oct 2026; event risk rises as the date approaches.
Options expected move3.4%Nearest-chain priced movement where available.
52-week drawdown-11.6%Distance below the 52-week high.
13-week volatility4.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+10.4%Week of 26 Jun.
Worst week-10.8%Week of 24 Apr.
Latest week+6.7%Week of 24 Jul.

Shape of recent returns

Strong gains4
Modest gains9
Flat weeks0
Modest losses6
Sharp losses7
Recent vol4.6%13-week weekly-return volatility.
Base vol4.7%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew3.6% / -3.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape50/100

Trend, activity pressure, participation, and risk combine to a 50/100 tape read.

 Indicator analysis24/100

Latest 12-week confirmation: trend 0/12, activity pressure 6/12, relative leadership 1/12.

Activity pressure 0.22; No reversal markers Factors41/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 27 SVQF33/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 680.5 of 1013 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options49/100

TMO shows bullish options pressure with a 36/100 conviction score, put-call volume ratio of 0.53, expected move of 3.4%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 3.4% Sentiment54/100

Weighted news tone is neutral across 39 relevant articles.

Thermo Fisher Scientific Inc. stock falls Monday, underperforms market Insiders18 / 2

18 acquisitions and 2 disposals in the latest 180-day insider tape.

 Earnings84d

Next report is scheduled for 21 Oct 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026568.3 USD6.7%512.6 USD522.4 USD0.901.0016.2MOff
17 Jul 2026532.5 USD1.0%513.0 USD522.4 USD0.78-5.898.8MOff
10 Jul 2026527.0 USD0.7%514.1 USD522.5 USD0.58-8.177.9MOff
3 Jul 2026523.4 USD2.0%515.6 USD522.5 USD0.44-7.569.0MOff
26 Jun 2026513.0 USD10.4%517.2 USD522.4 USD0.23-7.4113.0MOff
19 Jun 2026464.6 USD-0.9%519.7 USD522.4 USD0.07-18.078.8MOff
12 Jun 2026468.9 USD-0.7%523.8 USD522.8 USD-0.06-16.6610.9MOff
5 Jun 2026472.3 USD-4.0%527.4 USD523.2 USD-0.24-15.6710.9MOff
29 May 2026492.0 USD9.9%530.7 USD523.4 USD-0.41-14.4313.5MOff
22 May 2026447.8 USD2.3%533.1 USD523.6 USD-0.78-21.0611.8MOff
15 May 2026437.9 USD-5.7%537.2 USD524.0 USD-0.82-22.3013.9MOff
8 May 2026464.5 USD-0.9%540.5 USD524.6 USD-0.81-17.6212.2MOff
1 May 2026468.7 USD-0.1%542.5 USD524.9 USD-0.91-15.109.5MOff
24 Apr 2026469.2 USD-10.8%544.9 USD525.4 USD-0.93-14.4313.8MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.